Why Functional Integration Does Not Guarantee Regenerative Trajectories: A Structural Limit of Translational Bioengineering

In translational bioengineering, successful implantation, cell survival, and host integration are commonly interpreted as indicators of regenerative success. Yet many constructs that meet these criteria fail to sustain long-term tissue regeneration or functional maturation. This article advances a structural explanation for this discrepancy. We show that regenerative failure may arise not from insufficient bioactivity or poor engineering, but from an irreversible contraction of the system’s accessible regenerative trajectories. Drawing on recent work in mesenchymal stromal cell (MSC) therapies, metabolic adaptation, and host–construct interaction, we distinguish local functional integration from global regenerative accessibility. This Perspective reframes negative or ambiguous translational outcomes as structural limits rather than technical shortcomings, with direct implications for experimental design and interpretation in regenerative medicine.